BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 2865005)

  • 21. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P; Grifantini M
    Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).
    Lui MS; Faderan MA; Liepnieks JJ; Natsumeda Y; Olah E; Jayaram HN; Weber G
    J Biol Chem; 1984 Apr; 259(8):5078-82. PubMed ID: 6143752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
    Jayaram HN; Cooney DA; Grusch M; Krupitza G
    Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis.
    Catapano CV; Dayton JS; Mitchell BS; Fernandes DJ
    Mol Pharmacol; 1995 May; 47(5):948-55. PubMed ID: 7746281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targets and markers of selective action of tiazofurin.
    Weber G; Natsumeda Y; Pillwein K
    Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses.
    Huggins JW; Robins RK; Canonico PG
    Antimicrob Agents Chemother; 1984 Oct; 26(4):476-80. PubMed ID: 6151377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
    Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
    J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase.
    Yamada Y; Natsumeda Y; Weber G
    Biochemistry; 1988 Mar; 27(6):2193-6. PubMed ID: 2897864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: altered patterns of IMP dehydrogenase expression and activity.
    Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
    Cell Growth Differ; 1990 Jun; 1(6):259-70. PubMed ID: 1980599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
    Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IMP dehydrogenase and action of antimetabolites in human cultured blast cells.
    Yamada Y; Goto H; Yoshino M; Ogasawara N
    Biochim Biophys Acta; 1990 Mar; 1051(3):209-14. PubMed ID: 1968764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the antiviral nucleoside 2' ,3'-dideoxyguanosine.
    Ahluwalia G; Cooney DA; Bondoc LL; Currens MJ; Ford H; Johns DG; Mitsuya H; Fridland A
    Biochem Biophys Res Commun; 1990 Sep; 171(3):1297-303. PubMed ID: 1977386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity.
    Cooney DA; Jayaram HN; Glazer RI; Kelley JA; Marquez VE; Gebeyehu G; Van Cott AC; Zwelling LA; Johns DG
    Adv Enzyme Regul; 1983; 21():271-303. PubMed ID: 6152729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic cytotoxic effect of tiazofurin and ribavirin in hepatoma cells.
    Natsumeda Y; Yamada Y; Yamaji Y; Weber G
    Biochem Biophys Res Commun; 1988 May; 153(1):321-7. PubMed ID: 2897852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of IMP dehydrogenase prevent sindbis virus replication and reduce GTP levels in Aedes albopictus cells.
    Malinoski F; Stollar V
    Virology; 1981 Apr; 110(2):281-9. PubMed ID: 6111860
    [No Abstract]   [Full Text] [Related]  

  • 36. IMP dehydrogenase from the intracellular parasitic protozoan Eimeria tenella and its inhibition by mycophenolic acid.
    Hupe DJ; Azzolina BA; Behrens ND
    J Biol Chem; 1986 Jun; 261(18):8363-9. PubMed ID: 2873141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular targets of guanine nucleotides in differentiation, proliferation and apoptosis.
    Yalowitz JA; Jayaram HN
    Anticancer Res; 2000; 20(4):2329-38. PubMed ID: 10953293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
    Yamada Y; Natsumeda Y; Yamaji Y; Jayaram HN; Tricot GJ; Hoffman R; Weber G
    Leuk Res; 1989; 13(2):179-84. PubMed ID: 2564451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiazofurin and selenazofurin induce depression of cGMP and phosphatidylinositol pathway in L1210 leukemia cells.
    Parandoosh Z; Robins RK; Belei M; Rubalcava B
    Biochem Biophys Res Commun; 1989 Oct; 164(2):869-74. PubMed ID: 2554903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in vitro studies of Tiazofurin and a selenazole analog.
    Streeter DG; Robins RK
    Biochem Biophys Res Commun; 1983 Sep; 115(2):544-50. PubMed ID: 6138036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.